Multiple Sclerosis Update

New on the MedlinePlus Multiple Sclerosis page: New MS Drug Yields Mixed Results in Study 10/07/2015 05:00 PM EDT Relapse rates with daclizumab were lower than with a standard therapy, but side effects were greater Source: HealthDay Sun Exposure in Teen Years May Delay Onset of MS 10/07/2015 04:00 PM EDT But researchers only found a connection, not cause-and-effect link Source: HealthDay This email was sent to rssproject471@gmail.com.  Please click here to unsubscribe from the from the Multiple Sclerosis MedlinePlus email list.  Follow MedlinePlus on Twitter   Search Cloud: See what people are searching for on MedlinePlus To change your subscription preferences or stop subscriptions anytime, log in to your User Profile with your e-mail address. For questions or problems with this service, please contact subscriberhelp.govdelivery.com. This is a free service provided by MedlinePlus and the U.S. National Library of Medicine, U.S. Department of Health and Human Services, National Institutes of Health. U.S. National Library of Medicine · 8600 Rockville Pike · Bethesda, MD 20894 · 888-346-3656

Tweet

Postingan terkait:

— Thursday, October 8, 2015 — Add Comment